Table of Contents
This report forecasts US drug delivery product demand in US dollars at the manufacturers' level to 2019. Total demand is segmented by type in terms of: oral, parenteral, and other types. Total demand is also segmented by application as follows: central nervous system agents, hormones and related agents, respiratory agents, ant-infective agents, cardiovascular agents, gastrointestinal agents, and other applications.
To illustrate historical trends, total demand is provided in an annual series from 2004 to 2014; the various segments are reported at five-year intervals for 2009 and 2014. A Market Environment section provides pertinent background on historical trends, key economic indicators, trade, and pharmaceutical regulations. A Segmentation and Forecasts section defines product types and applications, discusses market drivers and constraints, identifies substitute products when applicable, and assesses the impact of key drivers and constraints on each product type and application segment over the forecast period.
Further analysis includes an Industry Structure section, which surveys the supply base and profiles the leading firms competing to serve the US market. A one-page, introductory Highlights section summarizes key findings from this 30-page report, and a Resources section lists contributing sources as well as resources available for further research.
Get Industry Insights. Simply.
Talk to Veronica
+1 718 514 2762
North America Facial Injectables Market: Overview This report on the North America facial injectables market analyzes the current and future prospects of the market. The report comprises an elaborate executive ...
Global Pulmonary Drug Delivery Devices Market: Overview This report on pulmonary drug delivery devices studies the current as well as future prospects of the market globally. The stakeholders of this report ...
The global injectable drug delivery market, in terms of value, is projected to reach USD 624.50 billion by 2021 from USD 362.38 billion in 2016, at a CAGR of 11.5% during the forecast period. The increase ...